CI
The Cigna Group
Stock
$270.53+2.57 (+0.96%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.4B | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $153.6B | $48.7B | $41.8B | $39.8B |
| SG&A | $14.2B | $14.6B | $14.8B | $14.8B | $13.2B | $13.0B | $14.1B | $14.1B | $11.9B | $10.0B | $9.8B |
| Operating income | $10.0B | $9.2B | $9.4B | $8.5B | $8.5B | $7.9B | $8.2B | $8.1B | $4.2B | $3.9B | $3.1B |
| Non-operating income | −$1.3B | −$1.4B | −$4.1B | −$3.0B | −$53M | −$1.2B | $2.7B | −$1.5B | −$579M | −$336M | −$109M |
| Pretax income | $8.6B | $7.8B | $5.3B | $5.5B | $8.4B | $6.8B | $10.9B | $6.6B | $3.6B | $3.6B | $3.0B |
| Taxes | $2.2B | $1.8B | $1.8B | $349M | $1.7B | $1.4B | $2.4B | $1.5B | $944M | $1.4B | $1.1B |
| Net income | $6.4B | $6.0B | $3.4B | $5.2B | $6.7B | $5.4B | $8.5B | $5.1B | $2.6B | $2.2B | $1.9B |
| Diluted EPS | $24.18 | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 |
| Diluted shares | — | 268.6M | 283.2M | 296.9M | 313.1M | 341.0M | 368.4M | 379.8M | 250.2M | 255.1M | 259.6M |
| Revenue growth | — | +11.2% | +26.6% | +8.2% | +3.7% | +8.5% | +4.5% | +215.7% | +16.4% | +4.9% | — |
| Operating margin | 3.5% | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | 9.4% | 7.8% |
| Net margin | 2.3% | 2.2% | 1.4% | 2.6% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | 5.4% | 4.7% |